Inaccurate and unnecessary cancer screening tests cost the U.S. healthcare system billions of dollars each year. New screening tools in development by NuView Life Science…
The recent shutdown of a major radioisotope production facility will potentially cause shortages of a vital medical isotope used worldwide in nuclear medicine procedures. US…
Traditional cancer diagnostic methods, including biopsies, are labor-intensive, expensive and invasive. NVLS is poised to change the way cancer is diagnosed with its new liquid…
Traditional methods of diagnosing malignant cancer are invasive, expensive, and not always accurate. Now, a new way to identify cancer cells stands ready to change…
